期刊文献+

脑星形细胞瘤MMP-9表达与微血管密度的关系及其意义 被引量:1

The study of relationship between expression of MMP-9 and microvessel density in astrocytoma
下载PDF
导出
摘要 目的:探讨不同类型脑星形细胞瘤组织中基质金属蛋白酶-9(MMP-9)的表达与微血管密度(MVD)的关系及其意义。方法:采用免疫组织化学(EnVision)方法检测50例星形胶质细胞瘤组织中MMP-9和CD34的表达,并通过CD34免疫组化结果测定肿瘤组织中MVD。结果:MMP-9在各型脑星形细胞瘤中均有不同程度的表达;不同组织学类型其阳性表达的强度存在统计学差异(Р<0.01)。Ⅲ~Ⅳ级脑星形细胞瘤组织中MMP-9的阳性表达为(76.52±3.38)%,MVD为(87.00±4.18)/高倍视野(HPF);Ⅰ~Ⅱ级中MMP-9的阳性表达为(27.90±2.53)%,MVD为(48.62±4.05)/HPF。Ⅲ~Ⅳ级中MMP-9和MVD的阳性表达明显高于Ⅰ~Ⅱ级(Р<0.01);脑星形细胞瘤中MVD和MMP-9的表达呈正相关。结论:MMP-9的表达和MVD与脑星形细胞瘤的组织学类型及恶性程度相关,有可能做为判断肿瘤恶性程度及预后的辅助指标。 Objective:To investigate the expression of MMP-9 in different kinds of astrocytoma,and their correlation with microvessel density(MVD),and relation with malignancy degree of astrocytoma.Methods:Immmunohistochemical staining was performed to detect the expression of MMP-9 and CD34 in astrocytoma of 50 cases.Expression of CD34 was used to estimate MVD.Results:Expression of MMP-9 protain were detected in all cases in astrocytoma.Positive rates were different in various astrocytomas.There are significant difference between the various groups(P〈0.01).Positive rates of MMP-9 was(76.52±3.38)% and MVD was(87.00±4.18)/HPF in WHO Ⅲ~Ⅳ grade astrocytomas.In WHO Ⅰ~Ⅱ grade,the expression levels were(27.90±2.53)% and MVD was(48.62±4.05)/HPF.The positive rates of expression of MMP-9 in WHO Ⅲ~Ⅳ grade was higher than in WHO Ⅰ~Ⅱ grade(P〈0.01);The expressions of MVD,MMP-9 present positive correlation in tissues of astrocytoma.Conclusion:It suggested that expression levels of MMP-9 and MVD were associaed with histological types and malignancy degree and may be markers to judge malignancy degree and prognosis in astrocytomas.
作者 陈志琴 顾霞
出处 《新疆医科大学学报》 CAS 2008年第9期1156-1158,共3页 Journal of Xinjiang Medical University
关键词 脑星形细胞瘤 基质金属蛋白酶-9(MMP-9) 微血管密度(MVD) 组织学分型 astrocytoma MMP-9 MVD histological types
  • 相关文献

参考文献8

  • 1岳伟英,陈忠平.胶质瘤治疗的新靶点[J].中国肿瘤,2006,15(3):155-157. 被引量:8
  • 2John A, Tuszynski G. The role of MMPs in tumor angiogenesis and tumor metastasis [J]. Pathol Oncol Res, 2001,7 (1):14-19.
  • 3Fotsyth PA, Wong H, Laing TD, et al. Gelatinaser A (MMP-2), gelatinaser B(MMP-9) and membrane type matrix metallopro7 teinase(MT1-MMP) are involved in different asppeeds of the pathophysiology of malignant gliamas[J]. Br J Cancer, 1999, 79 :1828-1833.
  • 4贺其图,赵晓华,贾国荣,马宏杰,李静,李喆,刘学文,云雁.白血病患者骨髓血管新生与Bcl-2蛋白关系的研究[J].实用癌症杂志,2006,21(4):376-378. 被引量:9
  • 5Kleiner D, Stetler-Stivenson W. Matrix metalloproteinases and metastasis[J]. Cancer Chemother Phamacol, 1999,43 (suppl) : 542-547.
  • 6Rao J S, Yamamoto M, Mohaman S, et al. Expression and localization of 92 kDa type Ⅳ collagenase/gelatinase B (MMP 9) in human gliomas[J]. Clin Exp Metastasis, 1996,14 ( 1 ):12-15.
  • 7Fina L,Molgaard HV, Robertson D,et al. Expression of the CD34 gene in vascular indothelial cells [J]. Blood, 1990, 75 (12) :2417-2426.
  • 8Pagenstecher A,Wussler EM,Opdenakker G, et al. Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in Primary Drain[J]. Tumors J Neuropathol EXP Neurol, 2001,60 (6) : 598-601.

二级参考文献17

  • 1康春生,浦佩玉,王广秀,李捷.反义及显性负调节AKT2抑制胶质瘤侵袭和迁移的实验研究[J].中国神经肿瘤杂志,2004,2(4):253-259. 被引量:6
  • 2徐喜慧,贺其图,贾国荣,宋芳,赵晓华,徐军.白血病患者骨髓血管新生的研究[J].白血病.淋巴瘤,2005,14(2):80-82. 被引量:9
  • 3Folkman J.Tumor angiogenesis:therapeutic implications[J].N Engl J Med,1971,285:1182-1186.
  • 4Maniotis AJ,Folberg R,Hess A,et al.Vascular channel formation by human melanoma cells in vivo and in vitro:vasculogenic mimicry[J].Am J Pathol,1999,155:739-752.
  • 5Hendrix MJ,Seftor EA,Hess AR,et al.Vasculogenic mimicry and tumour-cell plasticity:lessons from melanoma[J].Nat Rev Cancer,2003,3:411-421.
  • 6Folberg R,Hendiix MJ,Maniotis AJ.Vasculogenic mimicry and tumor angiogenesis[J].Am J Pathol,2000,156:361-381.
  • 7Yue WY,Chen ZP.Does vasculogenic mimicry exist in astrocytoma? [J].J Histochem Cytochem,2005,53:997-1002.
  • 8Hendrix MJ,Seftor EA,Hess AR,et al.Molecular plasticity of human melanoma cells[J].Oncogene,2003,22:3070-3075.
  • 9Ruf W,Seftor EA,Petrovan RJ,et al.Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry[J].Cancer Res,2003,63:5381-5389.
  • 10Shirakawa K,Tsuda H,Heike Y,et al.Absence of endothelial cells,central necrosis,and fibrosis are associated with aggressive inflammatory breast cancer [J].Cancer Res,2001,61:445 -451.

共引文献14

同被引文献22

  • 1张金锋.脑胶质瘤中血管内皮生长因子的研究进展[J].福建医科大学学报,2003,37(S1):42-44. 被引量:1
  • 2李燕敏.PINCH蛋白在脑胶质瘤中的表达及其临床意义[D].河北.河北医科大学.2008.
  • 3Riedal F, et al. Inverse correlation of apopmtie and angiogenic markers in squamous cell carcinoma of the head and neck..Oncol Rep, 2001, 8 (3) : 471- 476.
  • 4Nelson hR, et al. Matrix metal loproteinases: biologic activity and clinical implications. J Clin Oncol, 2000, 18 (5): 1135-1149.
  • 5Carfill RS, et al. KDR activation in astrocytic neo-plasms. Cancer, 1999, 86 (7): 1335-1341.
  • 6Pronin IN, et al. MRI of high- grade glial tumors:correlation between the degree of contrast enhancement and the volume of surrounding edema. Neuroradology, 1997, 39 (5) : 348- 350.
  • 7Esteve PO, et al. In vitro expression of MMP-2,MMP-9 in glioma cells following exposure to inflammatory mediators. Biochim Biophys Aeta, 1998,1403:85-96.
  • 8Takahashi M, et al. In vivo dioma growth requires host-derived matrix metalloproteinase 2 for maintenance of angioarchitecture. Pharmacol Res, 2002,46(2):155-163.
  • 9Nakada M, et al. Roles of membranetype 1 matrix metallo- proteioase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. J Neurosurg, 2001,94(3):464-473.
  • 10Struger J,et aI.Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg, 1994,81(5):560-566.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部